Changes in Actual Values of Immunologic Parameters Between Time Points Indicated
Variable . | Time Points . | Mean . | No. . | St. Dev. . | Min . | Median . | Max . | P . |
---|---|---|---|---|---|---|---|---|
CD4 | T1-T0 | 12.55 | 11 | 61.03 | −82 | 1 | 118 | .56 |
T2-T0 | 16.82 | 11 | 78.70 | −103 | 34 | 177 | .52 | |
T3-T0 | 72.27 | 11 | 79.52 | −39 | 59 | 221 | .01* | |
T4-T0 | 101.09 | 11 | 114.71 | −60 | 106 | 337 | .019 | |
CD8 | T1-T0 | 65.55 | 11 | 225.73 | −347 | 96 | 443 | .33 |
T2-T0 | 59.55 | 11 | 225.17 | −238 | 78 | 563 | .64 | |
T3-T0 | 86.82 | 11 | 244.49 | −272 | 78 | 570 | .28 | |
T4-T0 | 164.36 | 11 | 569.18 | −372 | 117 | 1585 | .76 | |
Apoptotic CD4 | T1-T0 | −14.04 | 11 | 11.81 | −33.4 | −12.0 | −0.2 | .0010* |
T2-T0 | −31.24 | 11 | 16.10 | −56.9 | −35.5 | −6.0 | .0010* | |
T3-T0 | −30.73 | 11 | 18.02 | −55.4 | −33.6 | −1.3 | .0010* | |
T4-T0 | −40.45 | 11 | 16.35 | −64.8 | −42.4 | −20.1 | .0010* | |
Apoptotic CD8 | T1-T0 | −5.51 | 11 | 5.35 | −16.5 | −6.5 | 1.2 | .0137* |
T2-T0 | −12.25 | 11 | 7.19 | −25.2 | −13.9 | −0.9 | .0010* | |
T3-T0 | −10.58 | 11 | 9.64 | −34.1 | −11.7 | 1.5 | .0029* | |
T4-T0 | −22.78 | 11 | 9.11 | −44.7 | −21.2 | −9.1 | .0010* | |
Ceramide | T1-T0 | −6.18 | 11 | 19.32 | −56.0 | 0 | 17.0 | .55 |
T2-T0 | −1.55 | 11 | 19.82 | −51.0 | −1.0 | 29.0 | .85 | |
T3-T0 | −19.55 | 10 | 20.63 | −64.0 | −12.0 | 0.0 | .002* | |
T4-T0 | −35.8 | 11 | 35.27 | −109.0 | −33.0 | 10.0 | .0029* |
Variable . | Time Points . | Mean . | No. . | St. Dev. . | Min . | Median . | Max . | P . |
---|---|---|---|---|---|---|---|---|
CD4 | T1-T0 | 12.55 | 11 | 61.03 | −82 | 1 | 118 | .56 |
T2-T0 | 16.82 | 11 | 78.70 | −103 | 34 | 177 | .52 | |
T3-T0 | 72.27 | 11 | 79.52 | −39 | 59 | 221 | .01* | |
T4-T0 | 101.09 | 11 | 114.71 | −60 | 106 | 337 | .019 | |
CD8 | T1-T0 | 65.55 | 11 | 225.73 | −347 | 96 | 443 | .33 |
T2-T0 | 59.55 | 11 | 225.17 | −238 | 78 | 563 | .64 | |
T3-T0 | 86.82 | 11 | 244.49 | −272 | 78 | 570 | .28 | |
T4-T0 | 164.36 | 11 | 569.18 | −372 | 117 | 1585 | .76 | |
Apoptotic CD4 | T1-T0 | −14.04 | 11 | 11.81 | −33.4 | −12.0 | −0.2 | .0010* |
T2-T0 | −31.24 | 11 | 16.10 | −56.9 | −35.5 | −6.0 | .0010* | |
T3-T0 | −30.73 | 11 | 18.02 | −55.4 | −33.6 | −1.3 | .0010* | |
T4-T0 | −40.45 | 11 | 16.35 | −64.8 | −42.4 | −20.1 | .0010* | |
Apoptotic CD8 | T1-T0 | −5.51 | 11 | 5.35 | −16.5 | −6.5 | 1.2 | .0137* |
T2-T0 | −12.25 | 11 | 7.19 | −25.2 | −13.9 | −0.9 | .0010* | |
T3-T0 | −10.58 | 11 | 9.64 | −34.1 | −11.7 | 1.5 | .0029* | |
T4-T0 | −22.78 | 11 | 9.11 | −44.7 | −21.2 | −9.1 | .0010* | |
Ceramide | T1-T0 | −6.18 | 11 | 19.32 | −56.0 | 0 | 17.0 | .55 |
T2-T0 | −1.55 | 11 | 19.82 | −51.0 | −1.0 | 29.0 | .85 | |
T3-T0 | −19.55 | 10 | 20.63 | −64.0 | −12.0 | 0.0 | .002* | |
T4-T0 | −35.8 | 11 | 35.27 | −109.0 | −33.0 | 10.0 | .0029* |
T0, baseline; T1, day 15; T2, day 30; T3, day 90; T4, day 150.
Abbreviation: St. Dev., standard deviation.
Significant at .05 level after Hochberg adjustment for multiple comparison.